Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
Clinical trial NCT04397601 · UNKNOWN
Trial details
- NCT number
- NCT04397601
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-11
- Primary completion
- 2023-05-11
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.